Ben Shamsian
Investor Relations, Lithlum Partners
Replay available
Biofrontera Inc. (NASDAQ: BFRI) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.

Investor Relations, Lithlum Partners
CEO, Chairman and Founder of BioFrontera
Analyst, The Benchmark Company
CFO, BioFrontera Inc.
Watch the replay and follow the connected company analysis, news, and investor updates for Biofrontera Inc..
WEBVTT 00:00:00.031 -- 00:00:05.219 Welcome to the BioFrontera Inc. Third Quarter 2025 Financial Results and Business 00:00:05.219 -- 00:00:09.545 Update Conference Call. All participants will be in a listen-only mode. 00:00:09.545 -- 00:00:12.970 Should you need assistance, please signal a conference specialist by pressing the star 00:00:12.970 -- 00:00:17.677 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:17.677 -- 00:00:22.163 questions. Please note, this event is being recorded. 00:00:22.163 -- 00:00:26.089 I would now like to turn the conference over to Ben Shamsian with Lithlum Partners Investor 00:00:26.089 -- 00:00:29.311 Relations. Please go ahead. 00:00:29.933 -- 00:00:35.441 Thank you. Good morning and welcome to Biofrantera Inc's third quarter fiscal year 2025 00:00:35.441 -- 00:00:39.226 financial results and business update conference call. 00:00:39.226 -- 00:00:43.933 Please note that certain information discussed during today's call by management is covered 00:00:43.933 -- 00:00:48.780 under the safe harbor provisions of the Private Securities Litigation Reform Act. 00:00:48.780 -- 00:00:53.787 We caution listeners that Biofrantera's management will be making forward-looking statements 00:00:53.787 -- 00:00:58.811 and that actual results may differ materially from those stated or implied by these 00:00:58.811 -- 00:01:04.198 forward-looking statements, the risks and uncertainties associated with the company's 00:01:04.198 -- 00:01:09.364 business. All risks and uncertainties are detailed and are qualified 00:01:09.364 -- 00:01:14.531 by the cautionary statements contained in BioFrontera's press releases and 00:01:14.531 -- 00:01:19.748 SEC filings. Also, this conference call contains time-sensitive informat...